Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 32 | 3,277 | 158 | 137 | 838 |
| Gross Profit | 32 | 3,277 | 158 | 137 | 838 |
| Operating Expenses | 19,531 | 27,262 | 33,362 | 25,001 | 15,699 |
| Operating Income | -19,499 | -23,985 | -33,204 | -24,864 | -14,861 |
| Interest Expense | 62 | -62 | 33 | 22 | 12 |
| Other Income | 131 | 34 | -273 | 59 | 9 |
| Pre-tax Income | -19,430 | -23,889 | -33,510 | -24,827 | -14,864 |
| Net Income Continuous | -19,430 | -23,889 | -33,510 | -24,827 | -14,864 |
| Net Income | $-19,430 | $-23,889 | $-33,510 | $-24,827 | $-14,864 |
| EPS Basic Total Ops | -0.44 | -0.56 | -0.81 | -0.60 | -0.38 |
| EPS Basic Continuous Ops | -0.44 | -0.56 | -0.81 | -0.60 | -0.38 |
| EPS Diluted Total Ops | -0.44 | -0.56 | -0.81 | -0.60 | -0.38 |
| EPS Diluted Continuous Ops | -0.44 | -0.56 | -0.81 | -0.60 | -0.38 |
| EBITDA(a) | $-19,380 | $-23,868 | $-32,919 | $-24,789 | $-14,787 |